6 articles · Updated · The New York Times · Apr 27
Patients using GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound report a sudden end to incessant food-related thoughts.
This phenomenon, described as 'food noise,' was previously unrecognized by researchers but is now prompting scientific inquiry into its origins and role in obesity.
Understanding how GLP-1 drugs affect food noise could reshape knowledge of obesity's causes and influence future treatments for weight management and related health conditions.
New pills may prevent weight regain after stopping Ozempic. Is this the end of lifelong medication?
Is silencing 'food noise' a cure, or just a mask for our toxic food environment?
Beyond weight loss, could these drugs be the next breakthrough in treating addiction?
Is 'food noise' a biological flaw, or a normal brain's response to an unnatural world?
Belly fat is linked to brain aging. Can new weight-loss drugs also prevent dementia?
What happens to our brains after years of silencing natural reward signals with these drugs?